IPSC- Century Therapeutics, Inc.

Name: Century Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Century Therapeutics, Inc. (IPSC) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. IPSC is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Pfeiffenberger Brent	3.32M	$7.61M	-
Other	Cowan Chad	1.18M	$2.69M	-
Other	Russotti Gregory	525.5K	$1.20M	-
VP	Carr Douglas	514.3K	$1.18M	-
Other	Farid Adrienne	250.1K	$572.8K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 9, 2026	Russotti Gregory83	See Remarks	Sell	479	$2.54	$1,214.74	-	-	-
Mar 9, 2026	Carr Douglas67	SVP Finance &Operations	Sell	247	$2.54	$626.39	-	-	-
Dec 22, 2025	Cowan Chad	Chief Scientific Officer	Buy	58,060	$0.85	$49,252.30	+5.9%	+175.9%	-
Dec 12, 2025	Pfeiffenberger Brent	President And CEO	Buy	52,000	$0.58	$30,352.40	+1.6%	+348.3%	-
Dec 8, 2025	Carr Douglas67	SVP Finance &Operations	Sell	257	$0.53	$136.72	-	+415.8%	-
Dec 8, 2025	Russotti Gregory83	See Remarks	Sell	526	$0.53	$279.83	-0.1%	+415.8%	-
Nov 20, 2025	Cowan Chad	Chief Scientific Officer	Sell	5,462	$0.50	$2,736.46	-0.6%	+328.0%	-
Nov 19, 2025	Pfeiffenberger Brent	President And CEO	Buy	35,000	$0.50	$17,328.50	+1.1%	+273.4%	-
Nov 17, 2025	Pfeiffenberger Brent	President And CEO	Sell	32,456	$0.45	$14,735.02	-1.0%	+301.8%	-
Nov 3, 2025	Carr Douglas67	SVP Finance &Operations	Sell	292	$0.59	$171.11	-	+206.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC